Efficacy of platelet-rich albumin and fibrin gel in two-stage lateral sinus lift: a prospective study.

IF 1.6 Q2 MEDICINE, GENERAL & INTERNAL
Annals of Medicine and Surgery Pub Date : 2025-07-25 eCollection Date: 2025-09-01 DOI:10.1097/MS9.0000000000003589
Moteea Barakat, Ali Khalil, Ziad Albash
{"title":"Efficacy of platelet-rich albumin and fibrin gel in two-stage lateral sinus lift: a prospective study.","authors":"Moteea Barakat, Ali Khalil, Ziad Albash","doi":"10.1097/MS9.0000000000003589","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Maxillary sinus lift procedures require biomaterials that combine osteogenic potential with structural stability. This study evaluates Albumin-Platelet-Rich Fibrin (Alb-PRF), a novel autologous material, as a standalone graft alternative in two-stage lateral sinus lifts, addressing limitations of rapid resorption in traditional platelet concentrates.</p><p><strong>Methods: </strong>A prospective study was conducted on nine patients (mean age: 48.5 years) with residual bone height <5 mm. Alb-PRF was prepared by heat-treating platelet-poor plasma to form an albumin gel, combined with PRF. The gel was placed via lateral window technique without supplemental grafts. Cone-beam computed tomography (CBCT) assessed vertical bone gain (VBG) and density at 6 months. Statistical analysis used paired <i>t</i>-tests (SPSS v22, α = 0.05).</p><p><strong>Results: </strong>Mean VBG was 5.07 ± 1.78 mm (range: 2.2-7.9 mm), with significant improvement from baseline (3.58 ± 1.2 mm to 8.65 ± 1.75 mm, *<i>P</i>* < 0.001). Radiographic bone density averaged 322.7 ± 36.4 Hounsfield units, indicating homogeneous osteogenesis. One membrane perforation occurred (11.11%), with no postoperative complications.</p><p><strong>Conclusion: </strong>Alb-PRF achieved clinically significant bone gain without traditional grafts, leveraging prolonged scaffold stability (4-6 months) and growth factor release. Its autologous nature and low complication profile make it a promising alternative, though larger studies are needed to validate long-term implant outcomes.</p>","PeriodicalId":8025,"journal":{"name":"Annals of Medicine and Surgery","volume":"87 9","pages":"5409-5416"},"PeriodicalIF":1.6000,"publicationDate":"2025-07-25","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12401425/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of Medicine and Surgery","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1097/MS9.0000000000003589","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/9/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"MEDICINE, GENERAL & INTERNAL","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Maxillary sinus lift procedures require biomaterials that combine osteogenic potential with structural stability. This study evaluates Albumin-Platelet-Rich Fibrin (Alb-PRF), a novel autologous material, as a standalone graft alternative in two-stage lateral sinus lifts, addressing limitations of rapid resorption in traditional platelet concentrates.

Methods: A prospective study was conducted on nine patients (mean age: 48.5 years) with residual bone height <5 mm. Alb-PRF was prepared by heat-treating platelet-poor plasma to form an albumin gel, combined with PRF. The gel was placed via lateral window technique without supplemental grafts. Cone-beam computed tomography (CBCT) assessed vertical bone gain (VBG) and density at 6 months. Statistical analysis used paired t-tests (SPSS v22, α = 0.05).

Results: Mean VBG was 5.07 ± 1.78 mm (range: 2.2-7.9 mm), with significant improvement from baseline (3.58 ± 1.2 mm to 8.65 ± 1.75 mm, *P* < 0.001). Radiographic bone density averaged 322.7 ± 36.4 Hounsfield units, indicating homogeneous osteogenesis. One membrane perforation occurred (11.11%), with no postoperative complications.

Conclusion: Alb-PRF achieved clinically significant bone gain without traditional grafts, leveraging prolonged scaffold stability (4-6 months) and growth factor release. Its autologous nature and low complication profile make it a promising alternative, though larger studies are needed to validate long-term implant outcomes.

Abstract Image

Abstract Image

Abstract Image

富血小板白蛋白和纤维蛋白凝胶在两期侧窦提升中的疗效:一项前瞻性研究。
背景:上颌窦提升手术需要结合成骨潜能和结构稳定性的生物材料。本研究评估了富白蛋白-血小板纤维蛋白(Alb-PRF),一种新的自体材料,作为两期侧窦提升的独立移植物替代方案,解决了传统血小板浓缩物快速吸收的局限性。方法:对9例患者(平均年龄48.5岁)进行前瞻性研究,采用剩余骨高度t检验(SPSS v22, α = 0.05)。结果:平均VBG为5.07±1.78 mm(范围:2.2-7.9 mm),从基线(3.58±1.2 mm)显著改善到8.65±1.75 mm, *P*结论:Alb-PRF在没有传统移植物的情况下获得了临床显著的骨增重,延长了支架稳定性(4-6个月)和生长因子释放。它的自体性和低并发症使其成为一个有希望的替代方案,尽管需要更大规模的研究来验证长期的植入效果。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
Annals of Medicine and Surgery
Annals of Medicine and Surgery MEDICINE, GENERAL & INTERNAL-
自引率
5.90%
发文量
1665
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术官方微信